0001305773-21-000003.txt : 20210106 0001305773-21-000003.hdr.sgml : 20210106 20210106194251 ACCESSION NUMBER: 0001305773-21-000003 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210104 FILED AS OF DATE: 20210106 DATE AS OF CHANGE: 20210106 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Augusti Mark A CENTRAL INDEX KEY: 0001481783 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37474 FILM NUMBER: 21512480 MAIL ADDRESS: STREET 1: 40 WEST HIGHLAND PARK DRIVE NE CITY: HUTCHINSON STATE: MN ZIP: 55350 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Conformis Inc CENTRAL INDEX KEY: 0001305773 STANDARD INDUSTRIAL CLASSIFICATION: ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 600 TECHNOLOGY DRIVE CITY: BILLERICA STATE: MA ZIP: 01821 BUSINESS PHONE: (781) 345-9001 MAIL ADDRESS: STREET 1: 600 TECHNOLOGY DRIVE CITY: BILLERICA STATE: MA ZIP: 01821 FORMER COMPANY: FORMER CONFORMED NAME: ConforMIS Inc DATE OF NAME CHANGE: 20041013 4 1 wf-form4_160998015904849.xml FORM 4 X0306 4 2021-01-04 0 0001305773 Conformis Inc CFMS 0001481783 Augusti Mark A C/O CONFORMIS, INC. 600 TECHNOLOGY PARK DRIVE BILLERICA MA 01821 1 1 0 0 President & CEO Common Stock 2021-01-04 4 S 0 61025 0.6417 D 2280345 D Common Stock 2021-01-05 4 S 0 32260 0.7479 D 2248085 D Represents the automatic sale of stock to cover the tax liability associated with the vesting of a Restricted Stock Award. The shares sold on this date were sold in multiple transactions. This price is the weighted average sales price per share of all shares sold on this date; the actual sale prices per share range from $0.64000-$0.64610, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. This sale was made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person. The shares sold on this date were sold in multiple transactions. This price is the weighted average sales price per share of all shares sold on this date; the actual sale prices per share range from $0.71350-$0.78500, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. /s/ J. Brent Alldredge, Attorney-in-Fact for Mark Augusti 2021-01-06